Organizing Committee and Speakers

Conference committee

Conference chair

Lynda Chin, MD

Lynda Chin, MD

President and CEO, Apricity Health LLC and Adjunct Professor, Dell Medical School, University of Texas, USA

Dr. Chin is an elected member of the National Academy of Medicine, a renowned cancer genomic scientist and a leader in application of technologies, AI/ML and big data in medicine.

View full bio

Organizing Committee

Anthony Chang MD

Anthony Chang MD

Chief Intelligence and Innovation Officer, Sharon Disney Lund Medical Intelligence and Innovation Institute (MI3), Children’s Hospital of Orange County, USA

Anthony Chang, MD, MBA, MPH, is a pediatric cardiologist and Medical Director of the Heart Failure Program at CHOC Children’s in Orange, CA.  Dr. Chang serves as CIIO of The Medical Intelligence and Innovation Institute (MI3). The institute is dedicated to implement data science and artificial intelligence in medicine.

View full bio

Keith T Flaherty, MD

Keith T Flaherty, MD

Director of Henri and Belinda Termeer Center for Targeted Therapy, Director of Clinical Research, Cancer Center, Massachusetts General Hospital and Professor, Medicine, Harvard Medical School, Harvard University, USA

Dr. Flaherty is Director of Clinical Research at the Massachusetts General Hospital Cancer Center, and Professor of Medicine at Harvard Medical School.

View full bio

Levi Garraway, MD PhD

Levi Garraway, MD PhD

Chief Medical Officer, Roche, USA

View full bio

Rosana Kapeller

Rosana Kapeller

Entrepreneur in Residence, GV, USA

Rosana Kapeller is an Entrepreneur in Residence at GV, focused on the intersection of therapeutics and machine learning. She brings over 25 years of scientific leadership and entrepreneurial experience to her role.

View full bio

Sean Khozin MD PhD

Sean Khozin MD PhD

Janssen R&D, Johnson & Johnson, USA

View full bio

Craig Mermel

Craig Mermel

Product Lead for Pathology at Google Health, Google AI, USA

Craig Mermel is currently the Product Lead for Pathology at Google Health. The team's goal is to accelerate the application of machine learning for improved diagnosis of important human diseases, especially cancer.

View full bio

Franziska Michor

Franziska Michor

Professor of Computational Biology, Department of Data Sciences, Dana-Farber Cancer Institute; Department of Stem Cell and Regenerative Biology, Harvard University; Department of Biostatistics, Harvard T.H. Chan School of Public Health, USA

Dr. Michor is a Professor of Computational Biology in the Department of Data Sciences at the Dana-Farber Cancer Institute, in the Department of Stem Cell and Regenerative Biology at Harvard University and in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health.

View full bio

Corrie Painter PhD

Corrie Painter PhD

Associate Director of Operations and Scientific Outreach for the Broad Cancer Program, Broad Institute, MIT and Harvard and Associate Director of Count Me In, USA

Corrie Painter is the associate director of operations and scientific outreach in the Cancer Program of the Broad Institute of MIT and Harvard. She leads the Angiosarcoma Project, a nationwide direct-to-patient genomics initiative aimed at generating the genomic landscape of this orphan disease, and she is working to build scientific resources to enable broad-scale rare cancer research across many indications.

View full bio

Manoj Saxena

Manoj Saxena

Executive Chairman, CognitiveScale and Founding Board Member, AI Global, USA

Manoj Saxena is the Executive Chairman of CognitiveScale and a founding Chairman of AI Global a non-profit dedicated to the ethical and responsible adoption of AI. Until recently, Saxena was Chairman of the board of the US Federal Reserve Bank of Dallas, San Antonio and served for six years in that role.

View full bio

Pam Sharma

Pam Sharma

Professor, Department of Genitourinary Medical Oncology; Professor, Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, USA

Dr. Sharma is a nationally and internationally renowned physician scientist whose research work is focused on investigating mechanisms and pathways within the immune system that facilitate tumor rejection, with subsequent clinical benefit, or elicit resistance to immune checkpoint therapy.

View full bio

David Shaywitz

David Shaywitz

Astounding HealthTech, USA

David’s career focus has been driving promising science into clinical impact; he’s especially interested in the transformational opportunities and implementation challenges presented by emerging technologies in drug development, from NGS and cell therapies to digital biomarkers and the meaningful application of AI.

View full bio

Ellen Sigal

Ellen Sigal

Chairperson & Founder of Friends of Cancer Research, USA

Ellen Sigal, PhD, is Chairperson and Founder of Friends of Cancer Research, a think tank and advocacy organization based in Washington that drives collaboration among partners from every healthcare sector to power advances in science, policy and regulation that speed life-saving treatments to patients.

View full bio

Keli Whitlock

Keli Whitlock

Partner, Duane Morris, USA

Keli Whitlock represents clients in connection with corporate and securities transactions, focusing on venture capital, public and private securities offerings, mergers and acquisitions and the representation of emerging growth and middle market companies.

View full bio

Speakers

Rosalyn Adam, PhD

Rosalyn Adam, PhD

Director of Urology Research, Boston Children's Hospital, USA

Dr. Adam is a basic scientist, with training in cell biology and biochemistry. She is the Director of Urology Research at Boston Children’s Hospital and Associate Professor of Surgery at Harvard Medical School. She received her PhD from the University of Southampton in the UK and came to Boston for postdoctoral training.

View full bio

<span id=Jeff Allen">

Jeff Allen

President and CEO, Friends of Cancer Research, USA

Jeff Allen, Ph.D. serves as the President and CEO of Friends of Cancer Research (Friends). During the past 20 years, Friends has been instrumental in the creation and implementation of policies ensuring patients receive the best treatments in the fastest and safest way possible.

Jeff Allen">

View full bio

<span id=Jim Allison, PhD">

Jim Allison, PhD

Chair, Department of Immunology, Division of Basic Science Research; Vivian L. Smith Distinguished Chair in Immunology, Department of Immunology; Executive Director, Immunotherapy Platform; Deputy Director, David H. Koch Center for Applied Research of Genitourinary Cancers; Director, Parker Institute for Cancer Immunotherapy (PICI), The University of Texas MD Anderson Cancer Center, USA 2018 Nobel Prize Winner for Physiology or Medicine

Dr. James Allison is the Regental Professor and Chair of the Department of Immunology, the Vivian L. Smith Distinguished Chair in Immunology, Director of the Parker Institute for Cancer Research, and the Executive Director of the Immunotherapy Platform at MD Anderson Cancer Center.

Jim Allison, PhD">

View full bio

<span id=Rick Berke">

Rick Berke

Co-founder and editor, STAT, USA

Rick Berke is co-founder and editor of STAT (statnews.com), a Boston-based media company with reporters around the country and in Asia covering health, medicine and life sciences. He was previously a longtime reporter and editor at the New York Times.

Rick Berke">

View full bio

<span id=Sarah Callaghan">

Sarah Callaghan

Editor in Chief, Patterns, Cell Press, Elsevier, USA

Dr Sarah Callaghan comes to Patterns from a 20-year career in creating, managing, and analyzing scientific data. Her research started as a combination of radio propagation engineering and meteorological modelling, then moved into data citation and publication, visualization, metadata, and data management for the environmental sciences.

Sarah Callaghan">

View full bio

<span id =Alicyn Campbell">

Alicyn Campbell

Head of Digital Heath for Oncology R&D, AstraZeneca and Founder, Patient Relevant Evidence, USA

Alicyn has over 12 years of experience in Health Outcomes Research. Most recently, she served as the Global Head of Patient Centered Outcomes Research at Genentech/Roche. In that capacity, she was responsible for leadership in the assessment of the patient experience and consulted widely with the FDA and international regulators.

Alicyn Campbell">

View full bio

<span id=Anthony Chang MD">

Anthony Chang MD

Chief Intelligence and Innovation Officer, Sharon Disney Lund Medical Intelligence and Innovation Institute (MI3), Children’s Hospital of Orange County, USA

Anthony Chang, MD, MBA, MPH, is a pediatric cardiologist and Medical Director of the Heart Failure Program at CHOC Children’s in Orange, CA.  Dr. Chang serves as CIIO of The Medical Intelligence and Innovation Institute (MI3). The institute is dedicated to implement data science and artificial intelligence in medicine.

Anthony Chang MD">

View full bio

<span id=Lynda Chin, MD">

Lynda Chin, MD

President and CEO, Apricity Health LLC and Adjunct Professor, Dell Medical School, University of Texas, USA

Dr. Chin is an elected member of the National Academy of Medicine, a renowned cancer genomic scientist and a leader in application of technologies, AI/ML and big data in medicine.

Lynda Chin, MD">

View full bio

<span id=Chris Coburn">

Chris Coburn

Chief Innovation Officer, Partners HealthCare System and President, Partners HealthCare International, USA

Chris Coburn is Chief Innovation Officer, Partners HealthCare System and President, Partners HealthCare International. Partners includes Brigham and Women’s, Massachusetts General, Massachusetts Eye and Ear, and McLean Hospitals with $13B in revenue, 1.5M patient visits and $1.8B in research expenditures.

Chris Coburn">

View full bio

<span id=Keith T Flaherty, MD">

Keith T Flaherty, MD

Director of Henri and Belinda Termeer Center for Targeted Therapy, Director of Clinical Research, Cancer Center, Massachusetts General Hospital and Professor, Medicine, Harvard Medical School, Harvard University, USA

Dr. Flaherty is Director of Clinical Research at the Massachusetts General Hospital Cancer Center, and Professor of Medicine at Harvard Medical School.

Keith T Flaherty, MD">

View full bio

<span id=Gad Getz PhD">

Gad Getz PhD

Professor, Pathology; Director of Bioinformatics, Harvard Medical School; Director, Cancer Genome Analysis, Broad Institute of MIT and Harvard; Massachusetts General Hospital Cancer Center, USA

Gady Getz is an internationally acclaimed leader in cancer genomics and is pioneering widely used tools for analyzing cancer genomes.

Gad Getz PhD">

View full bio

<span id=Kathy Giusti">

Kathy Giusti

Founder and Chief Mission Officer, Multiple Myeloma Research Foundation; Faculty Co-Chair; Harvard Business School-Kraft Precision Medicine Accelerator, USA

Kathy Giusti is the Founder and Chief Mission Officer of the Multiple Myeloma Research Foundation and Faculty Co-Chair of the Harvard Business School-Kraft Precision Medicine Accelerator.

Kathy’s innovative leadership has earned her numerous recognitions, including being named one of Fortune magazine’s 50 Greatest Leaders and TIME magazine’s 100 Most Influential People.

Kathy Giusti">

View full bio

<span id=Nancy Goodman, ">

Nancy Goodman,

Kids v Cancer, USA

After the death of her ten year old son Jacob, to cancer, Nancy Goodman founded Kids v Cancer and successfully championed the passage of two federal laws: the pediatric priority review voucher program in 2012, and the RACE for Children Act in 2017.

Nancy Goodman, ">

View full bio

<span id =Tufia C. Haddad MD">

Tufia C. Haddad MD

Oncologist, Mayo Clinic, USA

Dr. Tufia Haddad is an Associate Professor of Oncology at the Mayo Clinic College of Medicine and Science, and a Consultant in the Department of Oncology. Her clinical practice and research program is dedicated to breast cancer.  As an oncologist and clinical investigator, she is an active member of the Mayo Clinic Cancer Center, Women’s Cancer Research Program.

Tufia C. Haddad MD">

View full bio

<span id=William Hahn">

William Hahn

Chief Scientific Officer, Dana Farber Institute, Harvard University, USA

Dr. William C. Hahn is the William Rosenberg Professor of Medicine in the Department of Medical Oncology at the Dana-Farber Cancer Institute and Harvard Medical School and an Institute Member of the Broad Institute of MIT and Harvard. He is the Chief of the Division of Molecular and Cellular Oncology and the Chief Scientific Officer at the Dana-Farber Cancer Institute.

William Hahn">

View full bio

<span id=Colin Hill">

Colin Hill

Chairman, CEO and Co-Founder, GNS Healthcare, USA

Colin Hill is a leading voice in healthcare technology and co-founded precision medicine company GNS Healthcare in 2000 and has since served as Chairman & CEO. GNS uses a powerful form of AI, causal AI to match the right treatment to the right patient.

Colin Hill">

View full bio

<span id=Jonathan Hirsch">

Jonathan Hirsch

Founder and President, Syapse, USA

Jonathan Hirsch is the Founder and President of Syapse. Jonathan works closely with healthcare providers, life sciences partners, and regulatory agencies to create real world evidence-driven solutions that improve patient outcomes for cancer patients through precision medicine.

Jonathan Hirsch">

View full bio

<span id =Timothy Hoctor">

Timothy Hoctor

VP, Life Science Services, Elsevier, USA

Timothy Hoctor is Vice President of Professional Services for Elsevier, focusing on Life Science. Tim has held a variety of management and technical positions within Elsevier over a 22 year period, with a consistent focus on Pharmaceutical R&D. Prior to joining Elsevier, Tim held technical positions at Oracle, Sun Microsystems and other technology companies.

Timothy Hoctor">

View full bio

<span id=Rebecca Housel">

Rebecca Housel

Author, Blogger, Editor, USA

Dr. Rebecca Housel is an international best-selling author, editor and blogger, known for “Survive Anything: Learn How to Live Longer and Stronger” with Psychology Today, as well as her books on philosophy, pop culture, mental health, and Millennials.

Rebecca Housel">

View full bio

<span id=Rosana Kapeller">

Rosana Kapeller

Entrepreneur in Residence, GV, USA

Rosana Kapeller is an Entrepreneur in Residence at GV, focused on the intersection of therapeutics and machine learning. She brings over 25 years of scientific leadership and entrepreneurial experience to her role.

Rosana Kapeller">

View full bio

<span id=Iya Khalil, PhD">

Iya Khalil, PhD

Chief Commercial Officer and Co-Founder, GNS Healthcare, USA

Dr. Iya Khalil is a technology entrepreneur and physicist with a vision of transforming medicine into a discipline that is quantitative, predictive, and patient-centric via artificial intelligence and machine learning approaches.

Iya Khalil, PhD">

View full bio

<span id=Sean Khozin MD PhD">

Sean Khozin MD PhD

Global Head of Data Strategy, Janssen R&D, Johnson & Johnson, USA

Sean Khozin, MD, MPH is an oncologist, physician-scientist, and research affiliate at MIT. Dr. Khozin is the Global Head of Data Strategy for Janssen/J&J, focusing on incorporation of data science and advanced quantitative methods (including AI/ML) into R&D activities.

Sean Khozin MD PhD">

View full bio

<span id=Nikesh Kotecha PhD">

Nikesh Kotecha PhD

Vice President, Informatics, Parker Institute for Cancer Immunotherapy, USA

Nikesh leads the analytic and informatics efforts at the Parker Institute for Cancer Immunotherapy (PICI). The goal of PICI is to bring together the country’s leading immunologists and cancer centers is to accelerate the development of breakthrough immune therapies for cancer.

Nikesh Kotecha PhD">

View full bio

<span id=Becky Kusko">

Becky Kusko

Chief Strategy Officer, Immuneering Corporation, USA

Rebecca Kusko, PhD is Immuneering Corporation’s Chief Strategy Officer. She completed her undergraduate degree at MIT in Biological Engineering and earned a PhD in Genetics and Genomics from BU before joining Immuneering in 2014.

Becky Kusko">

View full bio

<span id=Mark Lee, MD, PhD">

Mark Lee, MD, PhD

SVP Global Head Personalized Healthcare, Product Development, Genentech

Mark Lee is a medical oncologist and the Global Head for Personalized Healthcare, Product Development at Genentech/Roche.

Mark Lee, MD, PhD">

View full bio

<span id=Constance Lehman, MD, PhD">

Constance Lehman, MD, PhD

Professor of Radiology, Harvard Medical School and Director of Breast Imaging & Co-Director of the Avon Breast Evaluation Center, Massachusetts General Hospital, USA

Constance “Connie” Lehman, MD, PhD is a Professor of Radiology at Harvard Medical School and Chief of Breast Imaging at Mass General Hospital.  She is a change agent, innovator, and pioneer in the domain of Artificial Intelligence implementation in clinical practice to improve breast cancer risk prediction, detection, diagnosis and treatment.

Constance Lehman, MD, PhD">

View full bio

<span id=Christoph Lengauer PhD">

Christoph Lengauer PhD

Partner, Third Rock Ventures; CSO, Celsius Therapeutics; Chief Innovation Officer at Thrive Earlier Detection, USA

Christoph Lengauer is a partner at Third Rock Ventures where he has been instrumental in launching several companies. Christoph currently serves as the CSO of Celsius Therapeutics as well as the chief innovation officer at Thrive Earlier Detection.

Christoph Lengauer PhD">

View full bio

<span id=King Li">

King Li

Carle Illinois College of Medicine, USA

King Li, M.D., MBA, is the inaugural dean and chief academic officer of the Carle Illinois College of Medicine at UIUC, the world's first engineering, data science and technology focused college of medicine.

King Li">

View full bio

<span id=Millie Liu">

Millie Liu

Founder, First Star VC, USA

Millie Liu has focused her career on helping entrepreneurs with deep technology turn their ideas into great businesses with global reach.

Millie Liu">

View full bio

<span id=Andrew W. Lo PhD">

Andrew W. Lo PhD

Charles E. and Susan T. Harris Professor; Professor, Finance; Director, Laboratory for Financial Engineering, MIT Sloan School of Management, USA

Andrew W. Lo is the Charles E. and Susan T. Harris Professor at the MIT Sloan School of Management, director of MIT’s Laboratory for Financial Engineering, and principal investigator at MIT's Computer Science and Artificial Intelligence Laboratory.

Andrew W. Lo PhD">

View full bio

<span id=Olaf Lodbrok">

Olaf Lodbrok

SVP & General Manager, Precision Medicine, Elsevier, Germany

Olaf Lodbrok is the Senior Vice President for Precision Medicine at Elsevier. He holds a Master’s degree in Electrical Engineering and Computer Science from Aachen University (Germany) and an MBA from Duke University (USA).

Olaf Lodbrok">

View full bio

<span id=Maura McCarthy">

Maura McCarthy

Uncommon Productions, USA

Maura McCarthy">

View full bio

<span id=Corey McMann MD PhD">

Corey McMann MD PhD

President and CEO, Pear Therapeutics, USA

Corey McCann, M.D., Ph.D., President and CEO of Pear Therapeutics, was previously an investor with MPM Capital, where he evaluated new healthcare investment opportunities, managed relationships with strategic partners, and oversaw strategy and execution at portfolio companies.

Corey McMann MD PhD">

Visit webpage

<span id=Craig Mermel MD PhD">

Craig Mermel MD PhD

Product Lead for Pathology at Google Health, Google AI, USA

Craig Mermel is currently the Product Lead for Pathology at Google Health. The team's goal is to accelerate the application of machine learning for improved diagnosis of important human diseases, especially cancer.

Craig Mermel MD PhD">

View full bio

<span id=Franziska Michor PhD">

Franziska Michor PhD

Professor of Computational Biology, Department of Data Sciences, Dana-Farber Cancer Institute; Department of Stem Cell and Regenerative Biology, Harvard University; Department of Biostatistics, Harvard T.H. Chan School of Public Health, USA

Dr. Michor is a Professor of Computational Biology in the Department of Data Sciences at the Dana-Farber Cancer Institute, in the Department of Stem Cell and Regenerative Biology at Harvard University and in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health.

Franziska Michor PhD">

View full bio

<span id=Spyro Mousses">

Spyro Mousses

Founder, Systems Oncology, USA

Dr. Mousses is the CEO of Systems Oncology LLC - an AI company which is transforming how cancer therapeutics are discovered and developed.

Spyro Mousses">

View full bio

<span id=Martin Murphy">

Martin Murphy

Chief Executive Officer, Project Data Sphere, USA

Dr. Martin J. Murphy DMedSc, PhD, FASCO is Founding CEO of the 18 year-old non-profit CEO Roundtable on Cancer at the request of the 41st President George H.W. Bush. Marty is also Founding CEO of Project Data Sphere® (PDS), a non-profit initiative devoted to cancer clinical trial data-sharing and data-analysis. Among other research, PDS is developing cancer clinical trials that: (1) avert the need to randomly put patients on a “comparator arm”, and (2) reduce/eliminate third-party radiological review. Both will speed drug development and efficacious cancer drug registration.

Martin Murphy">

View full bio

<span id=Mark Mynhier">

Mark Mynhier

Principal and General Manager, DoubleJump Interchange, PricewaterhouseCoopers, USA

Mark Mynhier is a principal in the Health Industry Advisory group at PricewaterhouseCoopers, LLP.  He has led the conceptualization and development of the DoubleJump Interchange™ (DJI) as a health data interchange for cross-enterprise data sharing and collaboration.

Mark Mynhier">

View full bio

<span id=Andrew Norden">

Andrew Norden

Chief Medical Officer, Cota Healthcare, USA

Dr. Norden is the Chief Medical Officer of COTA, where he leads COTA's medical and scientific activities. He is responsible for the quality and reliability of COTA's data curation operation and oversees research partnerships with academia, industry, non-profit organizations, and government agencies.

Andrew Norden">

View full bio

<span id=Ziad Obermeyer MD">

Ziad Obermeyer MD

Acting Associate Professor, University of California Berkeley School of Public Health, USA

Ziad Obermeyer studies questions in medicine and health policy using econometric methods and machine learning tools.
He is currently an Acting Associate Professor at the Berkeley School of Public Health where he teaches a seminar on machine learning for health policy PhD students, and a new undergraduate class on artificial intelligence for medicine and health policy.

Ziad Obermeyer MD">

View full bio

<span id=Dan O'Neil">

Dan O'Neil

RWJF Health Policy Fellow, National Academy of Medicine, USA

Dan ONeill served as a RWJF health policy fellow in 2018-2019, working on the staff of the Senate Committee on Health (HELP).

Dan O'Neil">

View full bio

<span id=Corrie Painter PhD ">

Corrie Painter PhD

Associate Director of Operations and Scientific Outreach for the Broad Cancer Program, Broad Institute, MIT and Harvard and Associate Director of Count Me In, USA

Corrie Painter is the associate director of operations and scientific outreach in the Cancer Program of the Broad Institute of MIT and Harvard. She leads the Angiosarcoma Project, a nationwide direct-to-patient genomics initiative aimed at generating the genomic landscape of this orphan disease, and she is working to build scientific resources to enable broad-scale rare cancer research across many indications.

Corrie Painter PhD ">

View full bio

<span id=Bakul Patel">

Bakul Patel

Director, Digital Health Division, Food and Drug Administration (FDA), USA

Bakul Patel is the Director of Digital Health Division, at the Center for Devices and Radiological Health (CDRH), at the Food and Drug Administration (FDA).  Mr. Patel is responsible for providing leadership, development, implementing, execution, management and setting strategic direction and regulatory policy and coordinate scientific efforts for digital health, software and emerging technologies.

Bakul Patel">

View full bio

<span id=Elizabeth Phillips Boudreau">

Elizabeth Phillips Boudreau

Healthcare Executive Advisor, Amazon Web Services (AWS), USA

Elizabeth Boudreau is a Healthcare Executive Advisor at Amazon Web Services (AWS) with over a 15 years of Healthcare IT experience. She works with customer executive teams globally to understand their mission and business drivers in order to assist them in developing appropriate strategies for sustainable cloud adoption.

Elizabeth Phillips Boudreau">

View full bio

<span id=Raul Rabadan PhD">

Raul Rabadan PhD

Professor, Department of Systems Biology, Columbia University, USA

Raul Rabadan is currently a tenured Professor at Columbia University with a joint appointment in the Department of Systems Biology and the Department of Biomedical Informatics, and the director of the Program for Mathematical Genomics at Columbia University and the Columbia University Center for Topology of Cancer Evolution and Heterogeneity, a NCI Physics and Oncology Center.

Raul Rabadan PhD">

View full bio

<span id=Manoj Saxena">

Manoj Saxena

Executive Chairman, CognitiveScale and Founding Board Member, AI Global, USA

Manoj Saxena is the Executive Chairman of CognitiveScale and a founding Chairman of AI Global a non-profit dedicated to the ethical and responsible adoption of AI. Until recently, Saxena was Chairman of the board of the US Federal Reserve Bank of Dallas, San Antonio and served for six years in that role.

Manoj Saxena">

View full bio

<span id =William Scherlis">

William Scherlis

Office Director, Information Innovation Office, DARPA, USA

Dr. William Scherlis assumed the role of office director for DARPA’s Information Innovation Office (I2O) in September 2019. In this role he leads program managers in the development of programs, technologies, and capabilities to ensure information advantage for the United States and its allies, and coordinates this work across the Department of Defense and U.S. government.

William Scherlis">

View full bio

<span id=Larry Schwartz">

Larry Schwartz

Chair, Department of Radiology, Columbia University Medical Center and Service Chief and Attending Physician, New York-Presbyterian Hospital, USA

Dr. Lawrence Schwartz is the James Picker Professor and Chairman for the Department of Radiology at Columbia University Medical Center.

Larry Schwartz">

View full bio

<span id=Pratik Shah">

Pratik Shah

Principal Research Scientist, MIT Media Lab, USA

Pratik Shah is a Principal Investigator and Principal Research Scientist at The MIT Media Lab and leads the Health 0.0 research program. His research creates novel intersections between engineering, medical imaging, machine learning, and medicine to improve health and diagnose and cure diseases.

Pratik Shah">

View full bio

<span id=Pam Sharma MD">

Pam Sharma MD

Professor, Department of Genitourinary Medical Oncology and Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, USA

Dr. Sharma is a nationally and internationally renowned physician scientist whose research work is focused on investigating mechanisms and pathways within the immune system that facilitate tumor rejection, with subsequent clinical benefit, or elicit resistance to immune checkpoint therapy.

Pam Sharma MD">

View full bio

<span id=Norman E. Sharpless MD">

Norman E. Sharpless MD

Director, National Cancer Institute; Chief, Aging Biology and Cancer Section, National Institute on Aging, USA

Norman E. “Ned” Sharpless, M.D., was officially sworn in as the 15th director of the National Cancer Institute (NCI) on October 17, 2017. Prior to his appointment, Dr. Sharpless served as the director of the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center, a position he held since January 2014.

Norman E. Sharpless MD">

View full bio

<span id=Ellen Sigal">

Ellen Sigal

Chairperson & Founder of Friends of Cancer Research, USA

Ellen Sigal, PhD, is Chairperson and Founder of Friends of Cancer Research, a think tank and advocacy organization based in Washington that drives collaboration among partners from every healthcare sector to power advances in science, policy and regulation that speed life-saving treatments to patients.

Ellen Sigal">

View full bio

<span id=Lauren Silvis ">

Lauren Silvis

Senior Vice President, External Affairs, Tempus and Former Chief of Staff at FDA, USA

Lauren Silvis serves as Senior Vice President of External Affairs at Tempus, overseeing regulatory, public policy and government affairs.

Lauren Silvis ">

View full bio

<span id=Gaurav Singal">

Gaurav Singal

Chief Data Officer, Foundation Medicine, USA

Gaurav Singal">

View full bio

<span id=Cathy Skinner">

Cathy Skinner

CEO, Thrivors, USA

Cathy Skinner is a nationally recognized ACSM Cancer Exercise Specialist with 9 years of working face-to-face with +400 cancer patients. In 2013, Skinner authored the Introduction to Exercise for Cancer Recovery™ which was utilized as a framework for THRIVORS™.

Cathy Skinner">

View full bio

<span id=Alicia C Staley">

Alicia C Staley

Senior Director, Patient Engagement, mHealth Medidata Solutions, USA

Alicia Staley is the Sr. Director Patient Engagement at Medidata. She has over 20 years of experience in software design and information systems management and works to infuse the patient perspective throughout the product development lifecycle and help engage patients in novel ways.

Alicia C Staley">

View full bio

<span id=David Vavrasek">

David Vavrasek

Chief People Officer, Aetion, USA

David is Chief People Officer at Aetion and has nearly 20 years of experience building and leading human resources teams across public, private, and VC-backed companies.  Aetion is a healthcare technology company that delivers real-world evidence to determine which treatments work best, for whom, and when.

David Vavrasek">

View full bio

<span id=Carlo Viamonte">

Carlo Viamonte

Medical Director, Anthem, USA

Dr. Viamonte is a medical director and radiology subject matter expert at Anthem. He is a neuroradiologist with research experience in clinical applications of AI.  He has a deep interest in quality/process improvement as well as the ethical development and implementation of AI to improve healthcare delivery.

Carlo Viamonte">

View full bio

<span id=Keli Whitlock">

Keli Whitlock

Partner, Duane Morris, USA

Keli Whitlock represents clients in connection with corporate and securities transactions, focusing on venture capital, public and private securities offerings, mergers and acquisitions and the representation of emerging growth and middle market companies.

Keli Whitlock">

View full bio

Stay informed

Get the latest conference updates by signing up to our event newsletter

Subscribe

Questions?

Have question about the conference or issues with registration

Contact us

Exhibit with us

To discuss your requirements or to book sponsorship or exhibit space please contact:
Carolina Ulloa Parra
Conference Sponsorship Sales Executive
STM Journals | Elsevier
Radarweg 29 | 1043NX Amsterdam | The Netherlands
T: +31 20 485 2125 | E-mail: c.ulloaparra@elsevier.com